DEPRESSION IN ADOLESCENTS - MYTH OR REALITY?

Authors

  • Catarina Resende Pediatric Department of CH Tondela-Viseu
  • Elisabete Santos Pediatric Department of CH Tondela-Viseu
  • Paulo Santos Pediatric Department of CH Tondela-Viseu
  • Alzira Ferrão Pediatric Department of CH Tondela-Viseu

DOI:

https://doi.org/10.25753/BirthGrowthMJ.v22.i3.10285

Keywords:

depression, adolescence, antidepressant, psychosomatic

Abstract

Introduction: Adolescence is a period of changes, making this phase more vulnerable to psychological disturbances. The Depressive Disorder is a clinical entity increasingly prevalent and may be a precursor of adult psychopathology.

Objectives: To evaluate the prevalence and characterize the population of adolescents with depressive syndrome in an adolescent consultation.

Methods: Retrospective and analytical study, based on data obtained from 91 medical records of patients followed in the adolescence office with the diagnosis of depressive syndrome in the period of January 2003 to December 2011.

Results: The diagnosis of depressive syndrome was made in 91 adolescents. There was a predominance of females. The average age of diagnosis was 14.8 years. The adolescents were referred mainly from the Primary Health Care and Emergency Paediatric (26.4 and 22%, respectively). The main symptoms at presentation were sadness / emotional lability / tearfulness (61.5%). Psychosomatic symptoms were quite prevalent accounting for 30.8%. In 64.8% of cases an unfavourable context was identified, and the family conl icts were the most frequent (38.5%). There was suicidal ideation in 28.6% of cases with para-suicide in 21%. In 60% it was necessary collaboration from other specialties (71% child psychiatry). Medication was started in 76.9% of adolescents, the most widely used drug was fluvoxamine.

Conclusion: Depressive disorder in adolescents has been increasing in recent years. Frequently, the Primary Health Care physicians are the first to contact with this situation. It is important the early identiÞ cation of adolescents at risk of developing this disease.

Downloads

Download data is not yet available.

References

Cook MN, Peterson J, Sheldon C. Adolescent depression:

an update and guide to clinical decision making. Psychiatry

; 6:17 -31.

Zuckerbrot RA, Cheung AH, Jensen PS, Stein RE, Laraque D.

GLAD -PC Steering Group. Guidelines for adolescent depression

in primary care (GLAD -PC): I. identiÞ cation, assessment,

and initial management. Pediatrics 2007; 120:e1299 -e1312.

Lobin L. Depression in adolescents: epidemiology, clinical manifestations

and diagnosis. Uptodate. Versão 19, Janeiro, 2012

(Acedido em 10/02/2012). Disponível em: www.uptodate.com.

Fleming JE, Offord DR. Epidemiology of childhood depressive

disorders: a critical review. J Am Acad Child Adolesc

Psychiatry 1990; 29:571 -80.

Lewinsohn PM, Clarke GN, Seeley JR, Rohde P. Major depression

in community adolescents: age at onset, episode

duration, and time to recurrence. J Am Acad Child Adolesc

Psychiatry 1994; 33:809 -18.

Lewinsohn PM, Rohde P, Klein DN, Seeley JR. Natural course

of adolescent major depressive disorder: I. Continuity into

young adulthood. J Am Acad Child Adolesc Psychiatry 1999;

:56 -63.

Rao U, Hammen C, Daley SE. Continuity of depression during

the transition to adulthood: a 5 -year longitudinal study

of young women. J Am Acad Child Adolesc Psychiatry 1999;

:908 -15.

Bonin L, Moreland CS. Overview of treatment for adolescent

depression. Uptodate. Versão 19, Janeiro, 2012 (Acedido em

/02/2012). Disponível em: www.uptodate.com

American Psychiatric Association. DSM IV -TR – Manual de

Diagnóstico e estatística das Perturbações Mentais. 4ª ed.

Lisboa: Climepsi editores, 2002.

Saluja G, Iachan R, Scheidt PC, Overpeck MD, Sun W, Giedd

JN. Prevalence of and risk factors for depressive symptoms

among young adolescents. Arch Pediatr Adolesc Med 2004;

:760 -5.

Birmaher B, Brent D, AACAP Work Group on Quality Issues,

Bernet W, Bukstein O, Walter H, et al. Practice parameter for

the assessment and treatment of children and adolescents

with depressive disorders. J Am Acad Child Adolesc Psychiatry

; 46:1503 -26.

March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, et

al. Fluoxetine, cognitive -behavioral therapy, and their combination

for adolescents with depression: Treatment for Adolescents

With Depression Study (TADS) randomized controlled

trial. JAMA 2004; 292:807 -20.

March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J,

et al. The Treatment for Adolescents With Depression Study

(TADS): long -term effectiveness and safety outcomes. Arch

Gen Psychiatry 2007; 64:1132 -43.

Moreland CS, Bonin L. Psychopharmacological treatment for

adolescent depression. Uptodate. Versão 19, Janeiro, 2012

(Acedido em 10/02/2012). Disponível em: www.uptodate.com

Souza LDM, Silva RS, Goodoy RV, Cruzeiro ALS, Faria AD,

Pinheiro RT, et al. Sintomatologia depressiva em adolescentes

iniciais – estudo de base populacional. J Bras Psiquiatr

; 57:261 -6.

Oliveira -Brochado F, Oliveira -Brochado A. Estudo da presença

de sintomatologia depressiva na adolescência. Revista

Portuguesa de Saúde Pública 2008; 26:27 -36.

Cordeiro R, Claudino J, Arriaga M. Depressão e suporte social

em adolescentes e jovens adultos. Revista Iberoamericana

de Educación 2006; 39:1 -9.

Cardoso P, Rodrigues C, Vilar A. Prevalência de sintomas

depressivos em adolescentes portugueses. Aná Psicológica

; 22:667 -75.

Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman

J, Dahl RE, et al. Childhood and adolescent depression: a

review of the past 10 years. Part I. J Am Acad Child Adolesc

Psychiatry 1996; 35:1427 -39.

Aragão TA, Coutinho MP, Araujo LF, Castanha AR. Uma perspectiva

psicossocial da sintomatologia depressiva na adolescência.

Ciênc Saúde Coletiva 2009; 14:395 -405.

Reppold CT. Prevalência de indicadores de depressão entre

adolescentes no Rio Grande do Sul. Aval psicol 2003; 2:175 -84.

Bahls SC. Aspetos clínicos da depressão em crianças e adolescentes.

J Pediatr 2002; 78: 359 -66.

Brito I. Ansiedade e depressão na adolescência. Rev Port

Clin Geral 2011; 27:208 -14.

Fonseca MHG, Ferreira RA, Fonseca SG. Prevalência de sintomas

depressivos em escolares. Pediatria 2005; 27:223 -32.

Avanci JQ, Assis SG, Oliveira R. Sintomas depressivos na

adolescência: estudo sobre fatores psicossociais em amostra

de escolares de um município do Rio de Janeiro, Brasil.

Cad Saúde Pública 2008; 24:2334 -46.

Uthman OA, Abdulmalik J. Comparative efÞ cacy and acceptability

of pharmacotherapeutic agents for anxiety disorders

in children and adolescents: a mixed treatment comparison

meta -analysis. Curr Med Res Opin 2010; 26:53 -9.

Maršani􀃼 VB, Margeti􀃼 BA, Margeti􀃼 B. Outpatient treatment

of children and adolescents with antidepressants in Croatia.

Int J Psychiatry Clin Pract 2012; 16:214 -22.

Sepehrmanesh Z, Alavi A, Arabgol F. Fluvoxamine for the

Treatment of Child and Adolescent. Depression: An Open Label

Trial. Iran J Psychiatry 2008; 3:11 -5.

Walkup J, Labellarte M, Riddle M, Pine D, Greenhill L, Klein

R, et al. Fluvoxamine for the treatment of anxiety disorders in

children and adolescents. N Engl J Med 2001; 344:1279 -85.

Published

2017-01-16

How to Cite

1.
Resende C, Santos E, Santos P, Ferrão A. DEPRESSION IN ADOLESCENTS - MYTH OR REALITY?. REVNEC [Internet]. 2017Jan.16 [cited 2024Feb.28];22(3):145-50. Available from: https://revistas.rcaap.pt/nascercrescer/article/view/10285

Issue

Section

Original Articles

Most read articles by the same author(s)